Alibaba IPO lifting Yahoo and Softbank

With interest building up ahead of Alibaba’s mega IPO on Friday (September 19), some investors have turned to trading its ‘proxies’ such as Yahoo and SoftBank.

Alibaba sign on window
Source: Bloomberg

According to Alibaba’s recent regulatory filing, it is aiming to raise up to $24.3 billion when it begins trading on the New York Stock Exchange under the code BABA.

Alibaba has set an IPO range of $60 to $66 a share, although this could be revised prior to the listing depending on how much interest it gets.

While the Chinese internet giant is still on a roadshow drumming up interest, there are reports that the IPO is already oversubscribed.

Notably, Yahoo and SoftBank have seen their stock prices benefiting from the ‘Alibaba effect’. Both were among the early investors in the Chinese e-commerce giant.

Yahoo’s 23% stake could be worth $26 billion, while Japanese telecoms giant SoftBank is sitting on a 34.4% stake, valued at more than $50 billion after the IPO.

That has attracted plenty of investor optimism, especially from those not expecting to get access to Alibaba’s new shares.

Since August, Yahoo’s stock price has run up over 20%, while Japan-listed SoftBank has jump 25%.

Click to enlarge

Is it too late for investors to jump on board these proxies?

Looking at Yahoo on a four-hour chart, we can see the stock price is on a long-term uptrend. The MACD has just crossed over the signal line, which indicates a buy signal.

Click to enlarge

Traders can look to take advantage of the momentum in the interim and refer to last week’s high of$41.80 as a potential support level.

What should be noted is that the RSI is above 70 and in overbought territory. This indicates a pullback could be on the cards once other indicators turn more bearish, such as if MACD crosses below the signal line.  More conservative traders can consider waiting for dips to buy on the uptrend.

Many similarities appear on SoftBank’s stock price chart, we can see an uptrend and some overbought signals because of the recent rally.

The stock price has broken through its recent resistance level of 7,902 yen and looks set to test its five-month high of 8,464 yen. If it breaks above this level, the next resistance it will test will be the 14-year high at 9,317.

There’s still a lot of positive momentum, as suggested by the Momentum indicator. The RSI, which is a lagging indicator, is pointing towards it being overbought. More conservative traders can wait for a retracement to support for a better entry.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.